Details for Patent: 10,987,364
✉ Email this page to a colleague
Which drugs does patent 10,987,364 protect, and when does it expire?
Patent 10,987,364 protects DROSPIRENONE and SLYND and is included in two NDAs.
This patent has sixty-five patent family members in twenty-nine countries.
Summary for Patent: 10,987,364
Title: | Synthetic progestogens and pharmaceutical compositions comprising the same |
Abstract: | Described herein are synthetic progestogens, such as 6.beta.,7.beta.:15.beta.,16.beta.-Dimethylene-3-oxo-17.alpha.-pregn-4-ene- -21,17-carbolactone, as well as pharmaceutical compositions comprising the same. Also described are methods of use. |
Inventor(s): | Perrin; Philippe (Paris, FR), Velada; Jose Luis (Amersfoort, NL), Drouin; Dominique (Verrieres-le-Buisson, FR) |
Assignee: | LABORATORIOS LEON FARMA SA (Leon, ES) |
Application Number: | 17/105,300 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 10,987,364
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Exeltis Usa Inc | DROSPIRENONE | drospirenone | TABLET, CHEWABLE;ORAL | 216285-001 | Jun 29, 2022 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
Exeltis Usa Inc | SLYND | drospirenone | TABLET;ORAL | 211367-001 | May 23, 2019 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,987,364
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2588114 | ⤷ Sign Up | CA 2020 00023 | Denmark | ⤷ Sign Up |
European Patent Office | 2588114 | ⤷ Sign Up | 2020C/518 | Belgium | ⤷ Sign Up |
European Patent Office | 2588114 | ⤷ Sign Up | 19/2020 | Austria | ⤷ Sign Up |
European Patent Office | 2588114 | ⤷ Sign Up | C202030026 | Spain | ⤷ Sign Up |
European Patent Office | 2588114 | ⤷ Sign Up | 301123 | Netherlands | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |